This figure is directly comparable to the performance of tirzepatide (Mounjaro) in the SURMOUNT-1 trial, which showed approximately 20.9% weight loss at 72 weeks, and exceeds the approximately 14.9% achieved by semaglutide alone in STEP 1
Theyre not drugs, but theyre commonly used as medications
These include: Lifestyle interventions (dietary advice, physical activity programmes) Licensed pharmacotherapy such as orlistat, or GLP-1 receptor agonists including semaglutide 2.4 mg (Wegovy, NICE TA875) or tirzepatide (Zepbound) where clinically indicated and available Referral to tier 3 or tier 4 weight management services , including bariatric surgery assessment where appropriate Information on NHS weight management services and eligibility for licensed treatments is available via the NHS website and NICE guidance
Telomere length and biological aging Cawthon RM et al
Semax Cognitive Support Protocol: One spray per nostril daily Semax is a neuroprotective peptide predominantly a nootropic, which has neurogenic/neurorestorative properties
Always consult a qualified healthcare provider before starting testosterone replacement therapy
